February 04, 2026 05:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move | PM Modi thanks 'dear friend' Trump for tariff reduction, hails strong US–India partnership | Trump announces US–India trade deal, lowers reciprocal tariffs to 18% | After Budget mayhem, bulls return: Sensex, Nifty stage sharp recovery | Dalai Lama wins first Grammy at 90 | Firing outside Rohit Shetty’s Mumbai home: 4 arrested, Bishnoi Gang link emerges | Female suicide attackers emerge at centre of deadly BLA assaults that rocked Pakistan’s Balochistan
COVID-19
Image Credit: UNI

India reports 41,195 new COVID-19 cases in 24 hours

| @indiablooms | Aug 12, 2021, at 04:27 pm

New Delhi/IBNS: In another spike in daily COVID-19 cases, India Thursday reported 41,195 new infections while the toll went up by 490 in the last 24 hours.

The country in the same period achieved the highest ever recovery rate, which is 97.45%, with 39,069 coronavirus patients recovering in 24 hours between Wednesday and Thursday mornings.

So far in the country, which was devastated by the second COVID-19 wave, 3,12,60,050 coronavirus patients have recovered.

The Union Health Ministry in its bulletin stated 52.36 crore anti-COVID-19 vaccine doses have been administered in the country of 1.3 billion people.

Meanwhile, the Drugs Controller General Of India (DCGI) has given its nod to a study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme.

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended such a study on Jul 29.

This study would be different from the one conducted by Indian Council of Medical Research (ICMR).

ICMR studied 18 people, 11 male, and seven female with a median age of 62 years, in Uttar Pradesh in India who received Covishield as the first dose followed by inadvertent administration of Covaxin, said the report.

The study revealed that vaccination with a combination of an adenovirus vector platform-based vaccine followed by an inactivated whole virus vaccine was not only safe but also triggered better immunogenicity, the top health body said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.